Skip to content

Sleep Inducing for EEG Recording in Children: A Comparison between Triclofos, Melatonin, Promethazine and Hydroxyzine for sedation during EEG in Children

Efficacy and safety of Triclofos, Melatonin, Promethazine and Hydroxyzine for sedation during EEG in Children: A Comparative triple blind randomized control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018713
Enrollment
650
Registered
2019-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G968- Other specified disorders of central nervous system

Interventions

Intervention1: Sedative Drugs: The purpose of this study is to compare efficacy and safety of 4 sedative drugs such as Triclofos (TL), promethazine (PZ), hydroxyzine (HZ) and melatonin (ML) for sedati

Sponsors

Leeha Singh principal investigator
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children aged 1-10 years, referred to EEG Unit of our hospital by a pediatric neurologist based on standard indications after a clinical assessment which was indicative of seizure or unclear spells or seizure-like events 2. Natural sleep could not be induced 3. Patient classified as American Society of Anesthesiology (ASA) class 1 (a normally healthy patient) or 2 (a patient with mild systemic disease: mild asthma, controlled diabetes mellitus)18.

Exclusion criteria

Exclusion criteria: 1. Presence of gastritis or any other serious systemic diseases 2. Any previous allergic reaction to any agent 3. Received a sedative or hypnotic agent within the past 48 hours 4. Severe tonsillar or adenoid hypertrophy 5. Being treated with medications that have critical interactions with these sedatives

Design outcomes

Primary

MeasureTime frame
Efficacy in adequate sedation and successful recording of EEG. Efficacy will be measured by following measures- 1.Total Sleep duration 2.Time from administration of the drug to adequate sedation (sleep onset latency) 3.Drowsiness time 4.Yield of seizure activity in the EEG 5.Requirement of repeated dosing of sedative for sleep induction 6.Care giverâ??s satisfaction on a Likert scale (from a scale of 1 to 5) 7.Total stay time in EEG unit Timepoint: Time taken to achieve complete sedation from the point of administration of sedative drug. Sedation level will be monitored for the entire time of EEG recording of 1 hour.

Secondary

MeasureTime frame
To assess the Adverse effectTimepoint: To be assessed from the point of administration of the drug to the point of complete EEG recording and till after 2 hours of the EEG recording

Countries

India

Contacts

Public ContactLEEHA SINGH

B. J. Wadia Hospital for Children

drleeha86@gmail.com09833027675

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026